Tour de Fox 2016 cycling series raises nearly $1m for Parkinson’s
Author: Almaz OhenePublished: 22 September 2016
Prep: Cook: Serves:
More than 5,700 individual donors supported the Tour de Fox 2016 series where 900 cyclists raised US$800,000 for Parkinson’s research
The Tour de Fox 2016 cycle series, which took place in three different cycling events locations in the US and Canada in July and August, saw more than 900 cyclists – just under 70 of those cyclists have Parkinson’s themselves – tackle rides of between 10 and 75 miles to raise money for the Michael J Fox Foundation.
In a blog post, Tour de Fox founder, Sam Fox, writes: “Those 900 riders inspired an incredible 5,700 individual donations for their efforts from friends, family, and generous strangers.
“All added up, the Tour has raised an impressive $800,000 (and counting!) to help close the gap on a cure.”
Sam Fox continued: “Continuing the trend set in 2015, the Tour de Fox Series was once again a big success. And once again, that success came from our passionate community of fundraisers.
“It has been amazing to see a project that was originally inspired by my own mother, grow and evolve into something that is capable of reaching people across the continent. Thanks to so many – our riders, their friends and families, our sponsors, and of course our volunteers – the Tour de Fox will continue to thrive, inspire, and raise crucial programmatic dollars for years to come. Thanks for coming out, and hope to see you all next year!”
Tour de Fox is the brainchild of ultra-athlete and Michael J Fox Foundation staffer Sam Fox (no relation to Michael J Fox) combining his athletic skills with his entrepreneurial spirit to raise funds for research and honour his mother, Lucy, who has lived with Parkinson’s disease since 2000.
His first big fundraiser for the Foundation was in 2011, when he ran around 2,500 miles from US-Canada border to the US-Mexico border.
In 2015, Sam undertook a 14,000-mile odyssey across the US and Canada. Over the three-month period, he climbed 49 high points in 48 states and travelled a total of 14,000 miles – 8,000 of those by bike – on his way to raising more than US$2.45 million.
Speaking out: Dad with Parkinson’s calls for better access to speech therapy
Documentary raises awareness for Parkinson’s speech therapy
6 days ago
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”
Could a specialised smartwatch support people with Parkinson’s disease?
A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…